Menicon Co., Ltd.
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Analyst Recommendations 4 analysts
Updated 2026/10/01Earnings Calendar
Updated 2026/10/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/08/06 | ¥15.92 | ¥30.05 | +88.8% |
| 2026/05/12 | ¥0.69 | ¥-5.56 | -905.8% |
| 2026/02/13 | ¥22.44 | ¥42.86 | +91.0% |
| 2024/02/12 | ¥27.90 | ¥16.47 | -41.0% |
Shareholder Composition
Updated 2026/10/01Top Mutual Funds / ETFs
Updated 2026/10/01Major Holders
Updated 2026/10/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
879.5K | 0.00% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
579.2K | 0.00% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
578.5K | +0.57% | |
|
DFA INVESTMENT TRUST CO-The Japanese Small Company Series
|
303.4K | +3.90% | |
|
DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT.
|
267.2K | +6.79% | |
|
VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Small-Cap
|
222.0K | +1.79% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Legato Capital Management LLC
|
171.9K | 0.00% |
Dividend History
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥28 | 0.0% |
| 2025 | ¥28 | +12.0% |
| 2024 | ¥25 | 0.0% |
| 2023 | ¥25 | +25.0% |
| 2022 | ¥20 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥100,172M | ¥110,194M | ¥116,192M | ¥121,491M |
| Gross Profit | ¥52,879M | ¥58,474M | ¥61,010M | ¥65,080M |
| Operating Income | ¥9,957M | ¥12,063M | ¥8,952M | ¥10,052M |
| Pretax Income | ¥10,232M | ¥11,879M | ¥7,686M | ¥10,029M |
| Net Income | ¥6,481M | ¥7,377M | ¥4,538M | ¥5,621M |
| EPS | ¥79.08 | ¥89.78 | ¥55.17 | ¥69.15 |
| Operating Margin | 9.94% | 10.95% | 7.70% | 8.27% |
| Balance Sheet | ||||
| Total Assets | ¥130,978M | ¥152,522M | ¥179,812M | ¥187,282M |
| Total Equity | ¥66,993M | ¥74,611M | ¥81,747M | ¥86,094M |
| Total Liabilities | ¥63,985M | ¥77,911M | ¥98,065M | ¥101,188M |
| Cash | ¥33,046M | ¥41,249M | ¥46,911M | ¥42,046M |
| Interest-bearing Debt | ¥42,435M | ¥53,579M | ¥70,793M | ¥75,089M |
| Equity Ratio | 51.15% | 48.92% | 45.46% | 45.97% |
| D/E Ratio | 0.63 | 0.72 | 0.87 | 0.87 |
| Cash Flow | ||||
| Operating CF | ¥12,719M | ¥12,749M | ¥11,866M | ¥13,944M |
| Investing CF | -¥16,149M | -¥13,776M | -¥21,575M | -¥19,661M |
| Financing CF | -¥5,402M | ¥8,900M | ¥14,554M | ¥714M |
| Free CF | -¥3,227M | -¥226M | -¥9,468M | -¥3,544M |
| Efficiency | ||||
| ROE | 9.67% | 9.89% | 5.55% | 6.53% |
| ROA | 4.95% | 4.84% | 2.52% | 3.00% |
Latest IR Information
-
Notice regarding the finalization of the details for stock-compensation type stock options (stock options) issued to our employees
Finalization of the allocation details for the 38th issue of stock-compensation type stock options for employees. The target is 1 employee, with 5 stock options allocated, a total of 5, and the payment per option is 136,000 yen (equivalent to...
Read more -
Q1 2027 Earnings Summary (Japanese GAAP)
Q1 FY2027 results announced. Revenue is expected to increase versus the previous quarter, with operating income and net income surpassing the year-ago level. Segments indicate solid growth in Vision Care, supported by strengthened domestic and international channels and new product...
Read more -
Menicon Co., Ltd. 2027 Fiscal Year 1Q Financial Summary
Announces the consolidated results for the first quarter of the 2027 fiscal year. Net sales show a growth trend versus the previous period, with the 1DAY business forming a larger share. Profitability improved YoY in operating income, EBITDA, and ordinary...
Read more -
Notice on the Issuance Details of Stock-Compensation-Type Stock Options (New Share Options) for Our Executive Officers, Directors, and Employees, and Directors and Employees of Our Subsidiaries
Issuance details of stock options have been finalized. Specifies the total units allocated and the paid-in amount for the 34th to 37th allocations (or not required). For the 37th allocation, the number of recipients and allocation decreased from the initial...
Read more -
[Menicon] Issuance of Share-based Stock Option | August 17, 2026
Menicon has decided to issue share-based stock options to employees, with the allocation scheduled for August 17, 2026.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥2,250
Rating Score: 1.75 (Based on 4 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Menicon Co., Ltd. produces and sells contact lenses in Japan and internationally. It operates through Vision Care Business and Others segments. The company offers disposable lenses, MTO specialty lenses, myopia management products, and lens care products. It also engages in the manufacture and sale of medical instruments; sale of medical supplies; research and development of intraocular lenses; healthcare business comprising products utilizing self-assembling peptide gel technology and bone graft substitute materials; life care business consisting of turf grass for green infrastructure; veterinary medical business, such as the sale of supplements for dogs and cats through animal hospitals and veterinary pharmaceutical wholesalers; and food business, including the sale and import/export of agricultural and marine products. The company sells its products to hospitals, ophthalmological clinics, optical shops, pharmaceutical wholesalers, and distributors. It exports its products to approximately 80 countries. Menicon Co., Ltd. was incorporated in 1943 and is headquartered in Nagoya, Japan.
